Evolution of the Average Target: Novo Nordisk A/S

Evolution of the Target Price: Novo Nordisk A/S

Changes in Analyst Recommendations: Novo Nordisk A/S

9ae.gudgIAOMG__QcRjR1yI13xCFKZckZRIGVLU02bbo_TY.9rY2SzrUUJaUJyiGvEoEnHW1G99XEl5VLfdSi_KgsU611VRocbRaspk4KA~c32d24ab0c1a6bc5cca8bd469ed09a43
Morgan Stanley initiates coverage of Novo Nordisk with Equal Weight and target price of DKK 700 - BN 12:28am FW
NOVO NORDISK : Gets a Neutral rating from Bernstein Feb. 11 ZD
NOVO NORDISK : Deutsche Bank remains its Buy rating Feb. 11 ZD
NOVO NORDISK : Gets a Buy rating from UBS Feb. 10 ZD
NOVO NORDISK : Deutsche Bank remains its Buy rating Feb. 10 ZD
NOVO NORDISK : Buy rating from Goldman Sachs Feb. 10 ZD
Goldman Sachs raises target price for Novo Nordisk to DKK 890 (875), reiterates Buy - BN Feb. 10 FW
NOVO NORDISK : UBS reiterates its Buy rating Feb. 07 ZD
DZ Bank cuts target price for Novo Nordisk to 630 Danish kroner (637), reiterates hold - BN Feb. 07 FW
NOVO NORDISK : DZ Bank reaffirms its Neutral rating Feb. 06 ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating Feb. 06 ZD
NOVO NORDISK : Receives a Buy rating from UBS Feb. 06 ZD
NOVO NORDISK : JP Morgan remains its Buy rating Feb. 06 ZD
Jyske Bank raises target price for Novo Nordisk to DKK 925 (850), reiterates Buy - BN Feb. 06 FW
JP Morgan cuts target price for Novo Nordisk to DKK 1,000 (1,050), reiterates Overweight - BN Feb. 06 FW
NOVO NORDISK : Q4 beat; encouraging 2025 outlook Feb. 05Alphavalue
NOVO NORDISK : Gets a Neutral rating from Bernstein Feb. 05 ZD
Novo Nordisk's profit estimate needs to be raised further according to analysts Feb. 05 FW
NOVO NORDISK : Buy rating from UBS Feb. 05 ZD
NOVO NORDISK : Goldman Sachs gives a Buy rating Feb. 05 ZD
NOVO NORDISK : JP Morgan maintains a Buy rating Feb. 05 ZD
NOVO NORDISK : Jefferies reiterates its Sell rating Feb. 05 ZD
NOVO NORDISK : UBS reiterates its Buy rating Feb. 03 ZD
Novo Nordisk expected to report SEK 33,627 million in operating profit - Bloomberg Feb. 03 FW
Carnegie lowers target price for Novo Nordisk to DKK 1,024 (1,090), reiterates Buy - BN Jan. 30 FW
More recommendations

Add to a list
Consensus 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+37.7%
+13.28%
+8.01%
+6.81%
+6.64%
+20.92%
+34.82%
+6.71%
+6.75%
+22.11%
Average +16.38%
Weighted average by Cap. +16.02%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
600.20DKK
Average target price
826.50DKK
Spread / Average Target
+37.70%
High Price Target
1,150.00DKK
Spread / Highest target
+91.60%
Low Price Target
515.00DKK
Spread / Lowest Target
-14.20%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BERNSTEIN RESEARCH Florent Cespedes
UBS Jo Walton
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
GOLDMAN SACHS James Quigley
DZ BANK Elmar Kraus
JPMORGAN Richard Vosser
alphavalue Abhishek Raval
JEFFERIES Peter Welford
BERENBERG Luisa Hector
Jyske Bank
BNP Paribas
Svenska Handelsbanken
ODDO BHF
BARCLAYS Emily Field
AlphaValue/Baader Europe
Argus
Stifel Nicolaus
BMO Capital
Cantor Fitzgerald
TD Cowen
Berenberg Bank
CREDIT SUISSE Lorenzo Biasio
Morgan Stanley
BNP Paribas Exane
JPMorgan Chase
Guggenheim
Bryan, Garnier & Co.
Deutsche Bank Securities
DEUTSCHE BANK Emmanuel Papadakis
Liberum Capital
KEPLER CHEUVREUX David Evans
HSBC Stephen McGarry
INDEPENDENT RESEARCH Tobias Gottschalt
BANK OF AMERICA (BOFA) Sachin Jain
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. Consensus Novo Nordisk A/S